Ten-year analysis of the prospective multicentre Chemo-N0 trial validates American Society of Clinical Oncology (ASCO)-recommended biomarkers uPA and PAI-1 for therapy decision making in node-negative breast cancer patients

Harbeck, N.; Schmitt, M.; Meisner, C.; Friedel, C.; Untch, M.; Schmidt, M.; Sweep, C. G. J.; Lisboa, B. W.; Lux, M. P.; Beck, T.; Hasmueller, S.; Kiechle, M.; Jaenicke, F.; Thomssen, C.

dc.contributor.author	Meisner, Christoph
dc.date.accessioned	2013-12-11T09:09:32Z
dc.date.available	2013-12-11T09:09:32Z
dc.date.issued	2013
dc.identifier.issn	0959-8049
dc.identifier.uri	http://hdl.handle.net/10900/39354
dc.language.iso	en	en
dc.publisher	Elsevier Sci Ltd	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.ejca.2013.01.007	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	Ten-year analysis of the prospective multicentre Chemo-N0 trial validates American Society of Clinical Oncology (ASCO)-recommended biomarkers uPA and PAI-1 for therapy decision making in node-negative breast cancer patients	de_DE
dc.type	Article	de_DE
utue.quellen.id	20130911224530_00849	de_DE
utue.publikation.seiten	1825-1835	de_DE
utue.personen.roh	Harbeck, N.
utue.personen.roh	Schmitt, M.
utue.personen.roh	Meisner, C.
utue.personen.roh	Friedel, C.
utue.personen.roh	Untch, M.
utue.personen.roh	Schmidt, M.
utue.personen.roh	Sweep, C. G. J.
utue.personen.roh	Lisboa, B. W.
utue.personen.roh	Lux, M. P.
utue.personen.roh	Beck, T.
utue.personen.roh	Hasmueller, S.
utue.personen.roh	Kiechle, M.
utue.personen.roh	Jaenicke, F.
utue.personen.roh	Thomssen, C.
dcterms.isPartOf.ZSTitelID	European Journal of Cancer	de_DE
dcterms.isPartOf.ZS-Issue	8	de_DE
dcterms.isPartOf.ZS-Volume	49	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE